An updated review of the use of omalizumab for the treatment of uncontrolled pediatric allergic asthma. Chipps BE, Garcia MF, Murphy KR, Haselkorn T, et al. J Allergy Clin Immunol 2024 Nov 15:S0091-6749(24)01228.

Read + Share

Amedeo Smart

Independent Medical Education

Chipps BE, Garcia MF, Murphy KR, Haselkorn T, et al. An updated review of the use of omalizumab for the treatment of uncontrolled pediatric allergic asthma. J Allergy Clin Immunol 2024 Nov 15:S0091-6749(24)01228.
PMID: 39551442